
	Glenn David is Senior Vice President of Finance Operations and Acting Chief Financial Officer (CFO) of Zoetis, the world leader in animal health medicines and vaccines.&nbsp; In this role, he is responsible for overseeing the financial management, reporting and shareholder relations for this $4 billion company, as well as its global procurement and operations.
	
	Mr. David was appointed Acting CFO in April 2014, after building a more than 20-year career in finance and operations roles across the human health, animal health and financial services industries.&nbsp; Most recently, Mr. David has served as Senior Vice President of Finance Operations for Zoetis, where he has led a team of more than 300 Finance professionals across 70 markets and played a critical role in the company&rsquo;s preparation and execution of its initial public offering (IPO) in 2013.
	
	Before the Zoetis IPO, Mr. David enjoyed a career in Finance at its former parent company, Pfizer.&nbsp; He served in various financial roles at Pfizer, including vice president of Global Finance for Pfizer Animal Health and vice president of Finance for the U.S. Primary Care franchise.&nbsp; Mr. David also played important financial roles in Pfizer&rsquo;s integration of the Pharmacia, Wyeth and King Pharmaceuticals&rsquo; acquisitions. &nbsp;
	
	Prior to joining Pfizer in 1999, Mr. David gained valuable financial experience at Bankers Trust, Paine Webber and Credit Suisse.
	
	Mr. David graduated magna cum laude with a bachelor&rsquo;s degree in Finance from Binghamton University, and earned his MBA in Finance/Information Technology from New York University.
	
	David resides in New Jersey with his wife and daughter.
